Piramal Pharma Limited announced a change in the generic email address for their Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited. The new email address, [email protected], will be effective from October 1, 2025. The previous email address, [email protected], will no longer be in use. This change impacts email communication for investors.
Email Update for Investors
Piramal Pharma Limited has updated the generic email address used for investor communications related to the Registrar and Share Transfer Agent (RTA). This change affects how investors can reach MUFG Intime India Private Limited, the company’s RTA, via email.
Details of the Change
The new generic email address for investors is [email protected]. This email will be effective from October 1, 2025. The old email address, [email protected], will be discontinued from this date.
Previous Communications
This change follows earlier intimations dated 2nd January, 2025, and 18th February, 2025, regarding the email update for the Company on change of its Generic e-mail address.
Source: BSE
